Investors today are cheering envudeucitinib's Phase 3 edge in oral TYK2 psoriasis as well as Alumis' plans to raise fresh ...

SpaceX is moving from private rocket champion to potential market supernova, with bankers and investors now treating a ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Agritech startup Arya.ag has raised $80.58 Mn (about INR 725 Cr) in its Series D round, in a mix of primary and secondary ...

If you are new to investing, the idea of primary vs secondary markets can feel confusing at first. You may hear about ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates ...

Solstice Finance’s USX briefly depegged to as low as $0.10 before liquidity injections restored it close to parity.

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.

What is the Market Size of Solid Electrolyte? Global Solid-State Electrolyte (SSE) market size in terms of revenue is projected to reach 218 Million USD by 2031 from 5.69 Million USD in 2024, with a ...

Doctolib, once France’s most valuable startup, was worth $6.4 billion at its previous funding round in 2022. French health tech Doctolib is in talks to raise a large secondary investment, in the range ...

Glorioso's Italian Market in Milwaukee will remain closed through the holiday season due to reconstruction delays. The market has been closed for months following a fire that damaged its second story ...